Caris Life Sciences (CAI) Cash Flow 2025-2026

Operating cash flow, free cash flow, FCF margin, and earnings quality

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $32.88M
Free Cash Flow: $22.53M
FCF Margin: 2.2%
FCF / Net Income: -44.2

FCF of $22.53M on $32.88M in operating cash flow. The FCF / Net Income ratio of -0.3x shows cash consumption — the business is not yet self-funding.

Operating Cash Flow

Cash generated from core business operations

Free Cash Flow

Cash the business generates after maintaining itself

FCF Margin (%)

10%+ signals a capital-efficient business model

FCF / Net Income

Above 1 means earnings are backed by real cash

Caris Life Sciences (CAI) Cash Flow 2025-2026

Operating cash flow, free cash flow, FCF margin, and earnings quality

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $32.88M
Free Cash Flow: $22.53M
FCF Margin: 2.2%
FCF / Net Income: -44.2

FCF of $22.53M on $32.88M in operating cash flow. The FCF / Net Income ratio of -0.3x shows cash consumption — the business is not yet self-funding.

Operating Cash Flow

Cash generated from core business operations

Free Cash Flow

Cash the business generates after maintaining itself

FCF Margin (%)

10%+ signals a capital-efficient business model

FCF / Net Income

Above 1 means earnings are backed by real cash